Lonza Bioscience Singapore Pte. Ltd.
Won 3 awards worth S$573k from 1 agency, between May 2021 and December 2022.
Company record
- UEN
- 200901608C
- Type
- Local Company
- Status
- Live Company
- Registered
- 2009-01-28
- Activity
- Contract mfg services of cell therapy applications/products for human use
From ACRA's register, matched by name. A match by name can be wrong.
Agencies
| Agency | Awards | Total | Share |
|---|---|---|---|
| Agency for Science, Technology and Research | 3 | S$573k |
Awarded each year
FY2021S$158k1 tender
FY2022S$416k2 tenders
FY2023S$00 tenders
FY2024S$00 tenders
FY2025S$00 tenders
Financial years run April to March: FY2025 is April 2025 to March 2026.
Every award Open in Explore
| Awarded | What for | Amount |
|---|---|---|
| 16 Dec 2022 | Supply and Delivery of Cryopreserved CD34+ Cord Blood Cells Agency for Science, Technology and Research · NST000ETT22000096 | S$217,800 |
| 19 Apr 2022 | Cryopreserved CD34+ Cord Blood Cells - For Research Use Only - Requested 30 batches of cells. One batch is from an individual donor For example, cells are collected from 30 different people/donor who has given consent. - At least two million viable cells after thawing from a single donor The cell should be cryopreserved in at least 0.5 million cells per vial, so there will be at least four vials from a single donor/batch - HLA data is required for individual donor. Agency for Science, Technology and Research · NST000ETT21000196 | S$198,000 |
| 3 May 2021 | Supply of Cryopreserved CD34+ Cord Blood Cells. Agency for Science, Technology and Research · NST000ETT20300120 | S$157,500 |